Multispan and Promega to Co-Develop Cell-Based GPCR Screening Tools | GenomeWeb
NEW YORK (GenomeWeb News) - Multispan and Promega said yesterday that they will co-develop assay tools for G-protein coupled receptor screening using Multispan’s GPCR cell lines and Promega’s bioluminescent technology.
The companies said that the initial tools to be developed under the agreement will use Promega’s cAMP-Glo Assay technology for signal quantification. The partners said they will develop additional tools for “cell-based assay detection,” but did not provide further details.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.